Americans are flocking to new weight loss medications like Novo Nordisk’s Wegovy and Eli Lilly's Zepbound, which work by ...

Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

If the plan pans out, it would be an enormous boon to Eli Lilly and Novo Nordisk. Currently, many health insurance plans, as ...

Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.

U.S. stocks drifted to a mixed finish on Thursday as President Donald Trump’s tariffs taking effect on dozens of countries ...

Healthcare earnings update: 93% of sector firms have reported, highlighting robust revenue growth & few misses.